Home > Healthcare > Medical Devices > Diagnostic Devices > Influenza Diagnostic Tests Market

Influenza Diagnostic Tests Market Share

Report ID: GMI4242
Published Date: Dec 2023
Report Format: PDF

Download Free Sample

Influenza Diagnostic Tests Market Share

The influenza diagnostic tests industry is fragmented in nature, with companies competing to offer superior influenza diagnostic tests in this business space. Prominent players such as F. Hoffmann-La Roche Ltd, Abbott, and Becton Dickinson and Company Inc hold a significant share in this market. These companies are diligently directing their efforts towards continuous type innovation to gain substantial market share.

Some of the eminent market participants operating in the influenza diagnostic tests industry include:

F. Hoffmann-La Roche Ltd
Abbott
Becton
Dickinson
Company
Coris BioConcept
DiaSorin SpA
Meridian Bioscience Inc
Quidel Corporation
Sekisui Diagnostics
Thermo Fischer Scientific Inc
Hologic Inc

Authors: Mariam Faizullabhoy , Gauri Wani

Frequently Asked Questions (FAQ) :

The influenza diagnostic tests market was valued at around USD 2.1 billion in 2022 and is estimated to reach over USD 3.9 billion by 2032, backed by the growing prevalence of influenza, rising demand for rapid diagnostic tests, and increase in R&D activities.

The traditional diagnostic test segment was valued at around USD 1.4 billion in 2022 and is expected to exhibit a robust growth trend through 2032, owing to their ease of use, quick results, and cost-effectiveness.

The U.S. influenza diagnostic tests market is anticipated to expand at a notable pace to reach more than USD 1.2 billion by 2032, attributed to robust healthcare infrastructure, R&D initiatives, and high disease burden, and seasonal outbreaks.

F. Hoffmann-La Roche Ltd, Abbott, Becton, Dickinson, and Company, Coris BioConcept, DiaSorin SpA, Meridian Bioscience Inc., Quidel Corporation, Sekisui Diagnostics, Thermo Fischer Scientific Inc., and Hologic Inc.